Skip to main content

1 Result(s)

within Article Remove this filter Olaf Rieß Remove this filter Biomedicine Remove this filter Apoptosis Remove this filter Immunology Remove this filter

and

  1. Article

    Open Access

    Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

    MEK inhibitors (MEKi) were shown to be clinically insufficiently effective in patients suffering from BRAF wild-type (BRAF WT) melanoma, even if the MAPK pathway was constitutively activated due to mutations i...

    Francisco Meraz-Torres, Heike Niessner… in Journal of Experimental & Clinical Cancer … (2024)

    Download PDF (5507 KB) View Article